Scientists have discovered that injecting a novel human protein into muscle affected by Duchenne muscular dystrophy significantly increases its size and strength, findings that could lead to a therapy akin to the use of insulin by diabetics. These results were published today in the Proceedings of the National Academy of Sciences by Dr. Julia von Maltzahn and Dr. Michael Rudnicki, the Ottawa scientist who discovered muscle stem cells in adults.
"This is an unprecedented and dramatic restoration in muscle strength," says Dr. Rudnicki, a senior scientist and director for the Regenerative Medicine Program and Sprott Centre for Stem Cell Research at the Ottawa Hospital Research Institute. He is also a Canada Research Chair in Molecular Genetics and professor in the Faculty of Medicine at the University of Ottawa.
"We know from our previous work that this protein, called Wnt7a, promotes the growth and repair of healthy muscle tissue. In this study we show the same types of improvement in a mouse model of Duchenne muscular dystrophy. We found that Wnt7a injections increased muscle strength almost two-fold, to nearly normal levels. We also found that the size of the muscle fibre increased and there was less muscle damage, compared to mice not given Wnt7a."
Duchenne muscular dystrophy is a genetic disorder that affects one of every 3,500 newborn males. In Canada, all types of muscular dystrophy affect more than 50,000 people. The disease often progresses to a state where the muscles are so depleted that the person dies due to an inability to breath. For people with Duchenne muscular dystrophy, this usually happens in their 20s or 30s.
"This is also exciting because we think it's a therapeutic approach that could apply to other muscle-wasting diseases," says Dr. Rudnicki.
Dr. Rudnicki's lab is a world leader in research on muscle stem cells. They have contributed significantly to our understanding of how these cells work at the molecular level. This basic research, which takes place in OHRI's multidisciplinary environment of collaboration with clinicians, led to the identification of Wnt7a as a promising candidate to help people with this muscle wasting disease.
Biotechnology partner, Fate Therapeutics is currently developing Wnt7a-based therapeutic candidates for treatment of muscular dystrophy and atrophy. Preclinical assessments are ongoing and the company plans to initiate clinical trials in the near future.
Ottawa Hospital Research Institute: http://www.ohri.ca
This press release was posted to serve as a topic for discussion. Please comment below. We try our best to only post press releases that are associated with peer reviewed scientific literature. Critical discussions of the research are appreciated. If you need help finding a link to the original article, please contact us on twitter or via e-mail.
Rising temperatures and a more acidic ocean may spell trouble for the Chesapeake Bay's iconic crabs, oysters and fish
Huge specimen caught in Antarctic waters by New Zealand fishing crew is one of few ever examined
Lonesome George, the worlds most famous tortoise, goes on display at the American Museum of Natural History.
Oxytricha trifallax lives in ponds all over the world. Under an electron microscope it looks like a football adorned with tassels. The tiny fringes are the cilia it uses to move around and gobble up algae. What makes Oxytricha unusual, however, is the crazy things it does with its DNA.
A Japanese woman with macular degeneration is the first person to be treated with induced pluripotent stem cells, made from her own skin
A DNA sequencer the size of a cell phone could change where, and how, gene research occurs.One day in 1989, biophysicist David Deamer pulled his car off California’s Interstate 5 to hurriedly scribble down an idea. In a mental flash, he had pictured a strand of DNA threading its way through a microscopic pore. Grabbing a pen and a yellow pad, he sketched out a radical new way to study the molecule of life.
New research led by the University of Leicester in the U.K. gives a blow-by-blow account of the injuries inflicted on King Richard III at the Battle of Bosworth Field on Aug 22, 1485. Modern forensic analysis of the King’s skeletal remains reveals that three of his injuries had the potential to cause death quickly.
Look into the jaws of a Mosasaurus and you will gaze into a nightmare.
Although it's far from the sort of brain transplant beloved by science fiction enthusiasts, scientists have taken one step in that direction: they have spliced a key human brain gene into mice.
A network in the brain that helps control daydreaming seem to be slower to develop in children with attention deficit hyperactivity disorder.